Zymeworks Wins FDA Approval for Ziihera in HER2+ GEA
VANCOUVER, British Columbia – August 25, 2026 Zymeworks Inc. announced that its partner Jazz Pharmaceuticals has received U.S. FDA...
HER2-positive GEA
Advertisement
Jazz Pharmaceuticals Gains FDA Approval for HER2+ GEA
Dublin, Ireland, August 25, 2026 Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved two...
BeOne Wins FDA Approval for TEVIMBRA HER2+ GEA Regimen
SAN CARLOS, Calif., August 25, 2026 BeOne Medicines Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
BeOne Medicines Reports Positive Phase 3 HERIZON-GEA Results at ASCO 2026
CHICAGO, Illinois and SAN CARLOS, California — May 27, 2026 BeOne Medicines announced new clinical findings from the Phase...
Advertisement
